544009

New Filing detected. See link for details.

New Filing detected. See link for details.

- Blue Jet Healthcare Limited announced the Qualified Institutions Placement (QIP) of equity shares. - The Investment and Finance Committee, on July 6, 2026, approved the preliminary placement document and set the floor price at ₹531.70 per Equity Share. - The QIP issue opened on July 6, 2026, with a potential discount of up to 5% on the floor price.

- Submission of Audited Standalone Financial Statements for the Financial Year ended March 31, 2026, approved by the Board on May 25, 2026. - Auditors (KKC & Associates LLP) noted disputed income tax liabilities totaling approx. ₹1768.86 million (net of deposits) for AY 2020-21 to 2023-24. - Internal control weaknesses were identified regarding audit trails: inventory records were manual in spreadsheets without audit trail up to December 7, 2025, and the auditor was unable to comment on the audit trail for third-party payroll software. - Title deeds for certain immovable properties (leasehold land and building) are still in the process of being transferred to the company after amalgamation/merger.

- Submitted Audited Standalone Financial Statements for FY26 with an unqualified audit opinion. - Board proposed final dividend for FY26. - Auditors noted manual inventory records, pending property title transfers, and significant disputed income tax dues for various assessment years.

- Trading window closed for Designated Persons and their immediate relatives as per SEBI (Prohibition of Insider Trading) Regulations, 2015. - Effective from July 1, 2026, until 48 hours after the declaration of Unaudited Standalone Financial Results for the first quarter ended June 30, 2026.

- Blue Jet Healthcare Limited announced the voting results of its EGM held on June 17, 2026. - A special resolution to approve raising of funds via issuance of Equity Shares and/or other Eligible Securities was passed with 99.9999% votes in favor.

- An Extra-Ordinary General Meeting (EGM) of Blue Jet Healthcare Limited was held on June 17, 2026, at 11:00 AM via Video Conferencing/OAVM. - The key agenda item was to consider and approve raising of funds by issuance of Equity Shares and/or other Eligible Securities through a special resolution. - E-voting facilities were provided, and the results of the voting will be declared within the stipulated time. - The meeting concluded at 11:29 AM IST.

- Blue Jet Healthcare Limited responded to an email from BSE/NSE dated June 12, 2026, regarding significant volume movement in its shares. - The company stated all necessary disclosures were made, and volume movement is due to market conditions.

New Filing detected. See link for details.

Blue Jet Healthcare described FY26 as a foundational year with significant investments, despite a decline in overall revenue and muted EBITDA primarily due to PI/API destocking. For FY27, management guided for double-digit growth in the contrast media segment, driven by 3-4 new product launches and backward integration. The PI segment is expected to recover and exceed FY25 peak levels as inventory destocking normalizes. The company plans a capex of approximately INR 1,000 crores over 3 years for the Vizag greenfield project and INR 40 crores for a new Hyderabad R&D center, targeting peptide-related intermediates and GLP-1 opportunities. Blue Jet Healthcare remains debt-free with strong liquidity, expecting improved business visibility and commercialization of new products in FY27.

Blue Jet Healthcare Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by Mehta and Mehta, Company Secretaries, confirms the company's full compliance with all applicable SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other relevant SEBI regulations and secretarial standards. No non-compliances, regulatory actions, or auditor resignations were observed during the review period.